Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.
Press releases published on April 12, 2025
Texas Hold'em Revolution: MLPoker Emerges as Premier Online Poker Destination in 2025
GlobeNewswire
·
April 12, 2025
MLPoker Image LOS ANGELES, April 12, 2025 (GLOBE NEWSWIRE) -- As the global poker community celebrates record-breaking participation in the 2025 World Series of Poker (WSOP), a new digital powerhouse is transforming online card gaming. MLPoker has rapidly …
ExoraPad Launches On Magnetic DEX, Set To Go Live on Mainnet By Q3 2025
GlobeNewswire
·
April 12, 2025
CORK, Ireland, April 12, 2025 (GLOBE NEWSWIRE) -- Investors who missed out on ExoraPad’s presale now have an ideal chance to join early, as $EXP token officially started trading on Magnetic DEX. The EXP/XRP trading pair is already seeing significant …
Vantage Biosciences 完成口服 VX-01 治疗非增殖性糖尿病视网膜病变第 2 期临床研究首例患者的给药
GlobeNewswire
·
April 12, 2025
伦敦, April 12, 2025 (GLOBE NEWSWIRE) -- Vantage Biosciences，一家推进糖尿病眼疾创新治疗的临床阶段生物技术公司，于今日宣布已在评估 VX-01 的第 2 期临床研究中成功完成首例患者的给药，VX-01 是治疗非增殖性糖尿病视网膜病变 (NPDR) 的一种口服疗法。 糖尿病视网膜病变影响全球超 1 亿人，也是劳动年龄段成人失明的主要诱因之一。 若未及时干预，NPDR 可能发展到糖尿病眼疾的更严重阶段，从而增加视力丧失的风险。 该里程碑标志着 VX-01 …
Vantage Biosciences 的口服藥 VX-01 用於治療非增生性糖尿病視網膜病變，在其第 2 期臨床研究中，首次安排患者完成服藥
GlobeNewswire
·
April 12, 2025
倫敦, April 12, 2025 (GLOBE NEWSWIRE) -- Vantage Biosciences 是一間臨床階段生物科技公司，致力開發治療糖尿病眼疾的創新療法。該公司今天宣布，在其評估 VX-01 的第 2 期臨床研究中，首次安排患者成功服藥。VX-01 是一種用於治療非增生性糖尿病視網膜病變 (NPDR) 的口服藥。 糖尿病視網膜病變影響全球逾 1 億人，是就業年齡成人失明的主要原因之一。 如果不及時介入，NPDR 可能會導致糖尿病眼疾的情況變得更加嚴重，增加視力受損的風險。 …
Volektra Raises Capital to Commercialize Virtual Magnet Motor for Mobility, Industry, and Defense
GlobeNewswire
·
April 12, 2025
SACRAMENTO, Calif., April 12, 2025 (GLOBE NEWSWIRE) -- Electric drivetrain innovator Volektra has secured a new funding round to commercialize its proprietary Virtual Magnet motor technology—an industry-first breakthrough that eliminates rare earth magnets …
Kane Biotech Announces New Agreement with Outside the Box Capital Inc.
GlobeNewswire
·
April 12, 2025
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba,, April 11, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (“Kane Biotech” or the “Company”) announces today that it has terminated …